【flashback fridays at golden nugget】With A 4.6% Return On Equity, Is Kilitch Drugs (India) Limited (NSE:KILITCH) A Quality Stock?
While some investors are already well versed in financial metrics (hat tip),flashback fridays at golden nugget this article is for those who would like to learn about Return On Equity (ROE) and why it is important. To keep the lesson grounded in practicality, we’ll use ROE to better understand Kilitch Drugs (India) Limited ( NSE:KILITCH ). Over the last twelve months Kilitch Drugs (India) has recorded a ROE of 4.6% . Another way to think of that is that for every ₹1 worth of equity in the company, it was able to earn ₹0.046. See our latest analysis for Kilitch Drugs (India) How Do You Calculate ROE? The formula for return on equity is: Return on Equity = Net Profit ÷ Shareholders’ Equity Or for Kilitch Drugs (India): 4.6% = 51.524 ÷ ₹1.1b (Based on the trailing twelve months to March 2018.) It’s easy to understand the ‘net profit’ part of that equation, but ‘shareholders’ equity’ requires further explanation. It is the capital paid in by shareholders, plus any retained earnings. You can calculate shareholders’ equity by subtracting the company’s total liabilities from its total assets. What Does Return On Equity Signify? ROE looks at the amount a company earns relative to the money it has kept within the business. The ‘return’ is the profit over the last twelve months. That means that the higher the ROE, the more profitable the company is. So, all else being equal, a high ROE is better than a low one . That means it can be interesting to compare the ROE of different companies. Does Kilitch Drugs (India) Have A Good Return On Equity? Arguably the easiest way to assess company’s ROE is to compare it with the average in its industry. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. As shown in the graphic below, Kilitch Drugs (India) has a lower ROE than the average (11%) in the Pharmaceuticals industry classification. NSEI:KILITCH Past Revenue and Net Income, March 1st 2019 That certainly isn’t ideal. We’d prefer see an ROE above the industry average, but it might not matter if the company is undervalued. Nonetheless, it might be wise to check if insiders have been selling . How Does Debt Impact Return On Equity? Companies usually need to invest money to grow their profits. The cash for investment can come from prior year profits (retained earnings), issuing new shares, or borrowing. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the use of debt will improve the returns, but will not change the equity. That will make the ROE look better than if no debt was used. Story continues Kilitch Drugs (India)’s Debt And Its 4.6% ROE Although Kilitch Drugs (India) does use a little debt, its debt to equity ratio of just 0.0082 is very low. Its ROE is certainly on the low side, and since it already uses debt, we’re not too excited about the company. Conservative use of debt to boost returns is usually a good move for shareholders, though it does leave the company more exposed to interest rate rises. The Key Takeaway Return on equity is useful for comparing the quality of different businesses. A company that can achieve a high return on equity without debt could be considered a high quality business. If two companies have the same ROE, then I would generally prefer the one with less debt. But ROE is just one piece of a bigger puzzle, since high quality businesses often trade on high multiples of earnings. Profit growth rates, versus the expectations reflected in the price of the stock, are a particularly important to consider. So I think it may be worth checking this free this detailed graph of past earnings, revenue and cash flow . Of course Kilitch Drugs (India) may not be the best stock to buy . So you may wish to see this free collection of other companies that have high ROE and low debt. We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. If you spot an error that warrants correction, please contact the editor at . This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading. View comments
相关推荐
-
Westland Insurance Acquires Diamond Insurance Agencies in Alberta
-
NEO Technical Analysis – Support Levels in Play – 01/02/19
-
Ohio State tops Washington 28-23 in Meyer's Rose Bowl finale
-
Cabinet approves merger of three state-owned banks
-
Monterey Minerals Provides Update on Drill Program
-
Ultima Thule Is a Distant, Icy Little Object, Just Like Your Father
- 最近发表
-
- Buy Ferrari Stock After Scuderia-Velas NFT deal?
- BRIEF-FGV Holdings Appoints Mohd Hairul Bin Abdul Hamid As CFO
- Takeover target RPC posts flat profit, to stockpile ahead of Brexit
- China's Jangho makes $1.2 bln bid for Australian medical centre owner Healius
- Euro Sun Mining Announces the Filing of a Business Acquisition Report in Connection with its Acquisition of Vilhelmina Minerals Inc.
- Consider This Commodity ETF in January
- Chilean supermarkets fined $12 mln for chicken price-fixing
- Four Business Trends Likely to Affect Your Corporate Legal Team in 2019
- A Magnificent Ascent For The Newest Cloud ETF
- 5 Money Tips for College Freshmen
- 随机阅读
-
- Shift Announces Its Intention to Commence an Offer to Exchange Its Publicly Traded Warrants
- Why CF Industries Holdings, Inc. (NYSE:CF) Is A Dividend Rockstar
- BRIEF-Hainan Yatai Industrial Plans To Buy 70 Pct Stake In Synthesis Med Chem (Hong Kong)
- 5 Top Stocks to Break the 'October Effect' Jinx
- More than one-third of small businesses may not last a month: poll
- Data Sheet—Burning Cash With China's Meituan-Dianping Delivery Service
- Plaintiffs Get Second Chance in Derivative Case Stemming From California Oil Spill
- BRIEF-Hytera Communications Expects To Win China Mobile's Bids For About 288 Mln Yuan
- One Metric To Rule Them All: Ground Rents Income Fund PLC (LON:GRIO)
- Costello Law Group Maryland Lawyers A Law Firm In Baltimore MD Wins Settlement Worth Millions For Their Clients
- Enterprise Products: 2Q Earnings Snapshot
- Canada finance minister hopes investment drive will offer example to G7
- Toy CEO says it 'sickens' him that people profit from a shortage of supplies to fight coronavirus
- BRIEF-Shanghai Pudong Development Bank's Board Gives Approval For Write-off
- Nintendo chief: Seeking growth sources as Switch sales slow
- BRIEF-Ronshine China Holdings Posts December Total Contracted Sales Of RMB13.66 Bln
- Galleon Gold Acquires Additional Interest in the Neal Gold Project and Increases Previously Announced Private Placement
- China to execute driver who killed passenger of ride-hailing firm Didi
- Prophecy Starts District Exploration at Pulacayo
- Nordstrom heir Blake Nordstrom dies at 58
- 搜索
-
- 友情链接
-
- Upcoming Deadline Reminder: The Schall Law Firm Encourages Investors in Redwire Corporation with Losses of $100,000 to Contact the Firm
- BRIEF-China Railway Construction's Consortium To Set Up Project Company For Railway Project
- Kathmandu Holdings (NZSE:KMD) Shareholders Have Enjoyed A 71% Share Price Gain
- Only 4 Days Left To Cash In On Scales Corporation Limited (NZSE:SCL) Dividend
- 4 Reasons to Add Essent Group (ESNT) Stock to Your Portfolio
- Do Directors Own Zenith Birla (India) Limited (NSE:ZENITHBIR) Shares?
- Can Jiashili Group Limited (HKG:1285) Maintain Its Strong Returns?
- January jobs report — What to know in markets Friday
- Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in U.S.
- Dominion Multiplies Solar Projects